GTC presented abstracts at ASCO 2025
GTC’s posters from the 2025 Convention of the American Society of Clinical Oncology are now available for download. Please reach out with any questions.
Limited Changes in the CNS Immune Microenvironment in Patients with Breast Cancer Metastasis to CNS and Capturing these Changes using Machine Learning.
Prevalence of the HPV, EBV and TTV viral RNA in the plasma of patients with solid and hematologic neoplasms and the detection of a specific immune signature
FOLR1 Expression Defines Pan-Cancer Subgroup of Tumors with Specific Transcriptomic Profile
Read more Articles and News from GTC
Genomic Testing Cooperative to Exhibit and Present Research at 2026 ASCO Annual Meeting
GTC will spotlight DNA and RNA-based precision oncology testing, liquid biopsy applications and research across hematologic malignancies, breast cancer metastasis and CNS involvement CHICAGO, May
GTC and Dr. Maher Albitar Featured in Houston Business Journal
Genomic Testing Cooperative and its founder and CEO, Dr. Maher Albitar, were recently featured in the Houston Business Journal in a “Face to Face” profile highlighting
ASCO 2026 Abstracts
Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Defining APOBEC-like signature in diffuse large B-cell lymphoma and demonstration of distinct transcriptomic profile. Presenter: Adam Albitar, MD
GTC opens Houston laboratory, expanding national precision oncology network
New central U.S. location strengthens testing capacity and turnaround times while positioning GTC within the Texas Medical Center ecosystem HOUSTON — March 12, 2026 — Genomic